Madrigal Pharmaceuticals

MDGLNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.784 B

$510.04 -0.06%

Close of 7 Aug 2026

Revenue

$180.1M

#2330 by revenue

Earnings

-$288.3M

Loss-making

Shares outstanding

23,104,126

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#29Biomarin PharmaceuticalBMRN$12.3B
#30Corcept TherapeuticsCORT$12.0B
#31Madrigal PharmaceuticalsMDGL$11.8B
#32AbivaxABVX$11.3B
#33Summit TherapeuticsSMMT$11.1B

Where these numbers come from

Share counts and financials for Madrigal Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.